Tianan Pharmaceutical Co Stock Performance
| TNPH Stock | USD 0.01 0.00 0.00% |
The entity has a beta of 0.0129, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Tianan Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Tianan Pharmaceutical is expected to be smaller as well. At this point, Tianan Pharmaceutical has a negative expected return of -0.0299%. Please make sure to validate Tianan Pharmaceutical's mean deviation, treynor ratio, as well as the relationship between the Treynor Ratio and day median price , to decide if Tianan Pharmaceutical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Tianan Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Tianan Pharmaceutical is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Total Cashflows From Investing Activities | -7119.00 |
Tianan |
Tianan Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 0.53 in Tianan Pharmaceutical Co on August 30, 2024 and sell it today you would lose (0.01) from holding Tianan Pharmaceutical Co or give up 1.89% of portfolio value over 90 days. Tianan Pharmaceutical Co is currently does not generate positive expected returns and assumes 0.2377% risk (volatility on return distribution) over the 90 days horizon. In different words, 2% of pink sheets are less volatile than Tianan, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Tianan Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tianan Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Tianan Pharmaceutical Co, and traders can use it to determine the average amount a Tianan Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.126
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TNPH |
Estimated Market Risk
| 0.24 actual daily | 2 98% of assets are more volatile |
Expected Return
| -0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Tianan Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tianan Pharmaceutical by adding Tianan Pharmaceutical to a well-diversified portfolio.
Tianan Pharmaceutical Fundamentals Growth
Tianan Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Tianan Pharmaceutical, and Tianan Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tianan Pink Sheet performance.
| Return On Equity | 0.25 | |||
| Return On Asset | 0.18 | |||
| Profit Margin | 0.30 % | |||
| Operating Margin | 0.36 % | |||
| Current Valuation | 979.64 K | |||
| Price To Earning | 0.15 X | |||
| Price To Book | 1.20 X | |||
| Price To Sales | 1.62 X | |||
| Revenue | 10.65 M | |||
| EBITDA | 4.31 M | |||
| Cash And Equivalents | 8.23 M | |||
| Cash Per Share | 0.59 X | |||
| Book Value Per Share | 1.03 X | |||
| Cash Flow From Operations | 2.56 M | |||
| Earnings Per Share | 0.01 X | |||
| Total Asset | 15.38 M | |||
| Retained Earnings | 4.96 M | |||
| Current Asset | 12.14 M | |||
| Current Liabilities | 853 K | |||
About Tianan Pharmaceutical Performance
By evaluating Tianan Pharmaceutical's fundamental ratios, stakeholders can gain valuable insights into Tianan Pharmaceutical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Tianan Pharmaceutical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Tianan Pharmaceutical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Tianan Pharmaceutical Co., Ltd. develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China. The company was founded in 2003 and is based in Xian, China. TianAn Pharm is traded on OTC Exchange in the United States.Things to note about Tianan Pharmaceutical performance evaluation
Checking the ongoing alerts about Tianan Pharmaceutical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Tianan Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Tianan Pharmaceutical generated a negative expected return over the last 90 days | |
| Tianan Pharmaceutical has some characteristics of a very speculative penny stock |
- Analyzing Tianan Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tianan Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Tianan Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Tianan Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tianan Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Tianan Pharmaceutical's pink sheet. These opinions can provide insight into Tianan Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Tianan Pink Sheet analysis
When running Tianan Pharmaceutical's price analysis, check to measure Tianan Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tianan Pharmaceutical is operating at the current time. Most of Tianan Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Tianan Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tianan Pharmaceutical's price. Additionally, you may evaluate how the addition of Tianan Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |